共 50 条
- [41] Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG) BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 169 - 176
- [42] Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG) Breast Cancer Research and Treatment, 2010, 119 : 169 - 176
- [43] Gemcitabine and cisplatin (GC) ± subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC):: Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG). JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 633S - 633S
- [47] Gemcitabine (GEM) plus Capecitabine (CAP) versus GEM alone in locally advanced or metastatic pancreatic cancer.: Aspects of quality of life in a randomized phase III study of the Swiss Group for Clinical Cancer Research (SAKK) and the Central European Cooperative Oncology Group (CECOG) EJC SUPPLEMENTS, 2005, 3 (02): : 203 - 204
- [50] European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology PEDIATRIC RADIOLOGY, 2021, 51 (10) : 1940 - 1951